Showing 101 - 110 of 247,714
The performances of African countries particularly in West African Sub- region on global-human development indices had been abysmal over the years and have worsened in the face of COVID-19 pandemic. This is a source of concern to scholars. Expenditure on health and education are recognized by...
Persistent link: https://www.econbiz.de/10013179620
Improved health, equity, macro-economic efficiency, efficient provision of care, and client satisfaction are the common goals of the health system. The relative significance of these goals varies, however, across nations, communities, and with time. As for health care finance, the attainment of...
Persistent link: https://www.econbiz.de/10013246051
Persistent link: https://www.econbiz.de/10013077983
"Problems related to the functioning of public healthcare systems encourage the search for alternative solutions, for example to ensure improved access to medical services. However, these proposals also require appropriate theoretical support to better present and apply them. This book draws on...
Persistent link: https://www.econbiz.de/10012643463
Persistent link: https://www.econbiz.de/10012748736
Persistent link: https://www.econbiz.de/10012749383
Roughly 95 percent of cross-national variation in child or infant mortality can be explained by a country's per capita income, the distribution of income, the extent of women's education, the level of ethnic fragmentation, and the predominant religion. Public spending on health has relatively...
Persistent link: https://www.econbiz.de/10012749393
"Health Economics and Financing is a primer for the economic analysis of medical markets. Its intended audiences are students of medicine, public health, policy, and administration who wish to engage the central economic issues of their field without prolonged preparatory work; beginning...
Persistent link: https://www.econbiz.de/10012694478
Persistent link: https://www.econbiz.de/10010191692
Recent outbreaks of infectious pathogens such as Zika, Ebola, and COVID-19 have underscored the need for the dependable availability of vaccines against emerging infectious diseases (EIDs). The cost and risk of R&D programs and uniquely unpredictable demand for EID vaccines have discouraged...
Persistent link: https://www.econbiz.de/10012481795